Selexipag

  • Part D specialty tier in 77% of formularies (2026Q3)
  • UPTRAVI

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Selexipag: storage and handling

Refrigerate
Yes, as the label states
Label statement
Storage conditions for UPTRAVI for injection: Store the original carton containing glass vial in a refrigerator at 2 °C to 8 °C (36 ºF to 46 ºF) until use in order to protect from light.
Freezing
Not addressed
Room temperature
at or below 30°C (86°F)
Label statement
Excursions are permitted between 15 °C and 30 °C (59 °F and 86 °F) [see USP Controlled Room Temperature].
Room temperature
at or below 25°C (77°F)
Label statement
Store UPTRAVI tablets at room temperature between 68 °F and 77 °F (20 °C and 25 °C).
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Storage conditions for UPTRAVI for injection: Store the original carton containing glass vial in a refrigerator at 2 °C to 8 °C (36 ºF to 46 ºF) until use in order to protect from light.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Excursions are permitted between 15 °C and 30 °C (59 °F and 86 °F) [see USP Controlled Room Temperature].

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-526-7736 (the number printed on the label) about this product.

Where the label prints this number
For more information, contact Actelion at 1-800-526-7736 or go to www.UPTRAVI.com.
All storage statements on the label (6)
  • Store at 20 °C to 25 °C (68 °F to 77 °F).
  • Excursions are permitted between 15 °C and 30 °C (59 °F and 86 °F) [see USP Controlled Room Temperature].
  • Recommended storage for UPTRAVI 100 mcg and 150 mcg tablets: Store and dispense in the original package to protect from moisture.
  • Storage conditions for UPTRAVI for injection: Store the original carton containing glass vial in a refrigerator at 2 °C to 8 °C (36 ºF to 46 ºF) until use in order to protect from light.
  • Store UPTRAVI tablets at room temperature between 68 °F and 77 °F (20 °C and 25 °C).
  • Store UPTRAVI 100 mcg or 150 mcg tablets in the original package to protect from moisture.

FDA label version 26, effective May 28, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

60%of plans list it
97%of those: prior authorization
0%step therapy
94%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.